Companies operating in the biologics and biosimilars space are navigating a period of rapid change, shaped by evolving intellectual property strategies, regulatory developments, and increasing competitive pressure.
As innovation accelerates and global competition intensifies, organizations must balance product development, market access, and risk management while protecting valuable IP assets and responding to shifting legal and regulatory expectations.
Speaking Engagement
Thomas J. Campbell Jr., Partner
Uncertainty at the Intersection of Artificial Intelligence and IP Strategies: Has AI Altered Product Development and Litigation Planning?
June 2
Tom Campbell will join industry leaders to discuss how artificial intelligence is transforming biologics development, intellectual property strategy, and litigation planning.
As AI tools are increasingly used in molecule design, patent analytics, and competitive intelligence, companies are facing new legal and operational questions that directly impact innovation and risk.
The discussion will focus on:
- Governance approaches for responsible AI implementation in research and development
- Managing contractual risk with AI vendors and development partners
- Strengthening intellectual property protections, including inventorship and documentation practices
- Preparing for litigation and evidentiary challenges tied to AI assisted innovation
- Coordinating across legal, compliance, and scientific teams to align strategy
How We Support Biosimilars and Biologics Companies
Our Life Sciences and Intellectual Property teams work with companies across the product lifecycle, helping them navigate complex legal and business challenges in highly competitive markets.
We regularly advise on:
- Intellectual property strategy for biologics and biosimilars, including portfolio development and lifecycle planning
- Regulatory and market positioning considerations that impact commercialization and access
- AI and data driven innovation, including emerging risks related to ownership, inventorship, and compliance
- Dispute strategy and risk mitigation in high stakes, IP intensive environments
Our approach integrates legal, regulatory, and business considerations to help organizations protect innovation, reduce risk, and compete effectively.
